|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
||||||||||||||
|
||||||||||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=sEDF61960-3BC0-11EF-8F73-002B85CE164B&I=39IZM&T=&OP=Display&O=html&O1=12911984&O2=1000000000394220&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3DEthoxidol%2520as%2520a%2520Broad-spectrum%2520Adaptogen%26rft.au%3DElena%252C%2520Mil%26rft.au%3DIrina%252C%2520Zhigacheva%2520V%26rft.au%3DNatalya%252C%2520Krikunova%2520I%26rft.au%3DVladimir%252C%2520Binyukov%2520I%26rft.date%3D2023-01-01%26rft.eissn%3D1874-4702%26rft.externalDocID%3D35260065%26rft.genre%3Darticle%26rft.issue%3D1%26rft.jtitle%3DCurrent%2520molecular%2520pharmacology%26rft.spage%3D109%26rft.volume%3D16%26rft_id%3Dinfo%253Adoi%252F10.2174%252F1874467215666220308115514%26rft_id%3Dinfo%253Apmid%252F35260065%26rft_id%3Dinfo%253Apmid%252F35260065%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-MESSAGE_NO_FULLTXT_LCL-getMessageNoFullTxt-object,2-COBIB_SI_LCL-getHolding-object,3-DOI-getDOI-object,4-ELSEVIER_SCOPUS_FIS_LCL-getAbstract-object,5-REFWORKS_EXPORT_TOOL-getReference-object,6-NCBI_PUBMED_FREE-getCitedRecord-object,7-SHERPA_RoMEO_LCL-getWebService-object,8-GOOGLE_SCHOLAR_FREE-getWebSearch-object,9-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=1.682747&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:12911984-sEDF61960-3BC0-11EF-8F73-002B85CE164B" timestamp="2024-07-06T19:55:29Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:1000000000394220</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>Ethoxidol as a Broad-spectrum Adaptogen</jnl:atitle>
<jnl:jtitle>Current Molecular Pharmacology</jnl:jtitle>
<jnl:date>2023-02-00</jnl:date>
<jnl:spage>109</jnl:spage>
<jnl:epage>115</jnl:epage>
<jnl:issn>1874-4672</jnl:issn>
<jnl:volume>16</jnl:volume>
<jnl:issue>1</jnl:issue>
<jnl:genre>article</jnl:genre>
<jnl:eissn>1874-4702</jnl:eissn>
<jnl:language>eng</jnl:language>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:3088815b914ce4e06a27de6f6fb465abc78d5ac0</ctx:identifier>
<ctx:identifier>urn:UUID:sEDF61960-3BC0-11EF-8F73-002B85CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)